Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system.

Karen Mandel1, Yigal Dror, Annette Poon

  • 1Division of Hematology/Oncology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Ontario, Canada.

Journal of Pediatric Hematology/Oncology
|July 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.

Journal of pediatric hematology/oncology·2026
Same author

A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium.

Journal of pediatric hematology/oncology·2026
Same author

Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative study.

Haematologica·2026
Same author

Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure Registry.

European journal of haematology·2026
Same author

Expanding genetic landscape of inherited bone marrow failure syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023).

British journal of haematology·2026
Same author

Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation.

Pediatric transplantation·2026
Same journal

Assessment of Immunization Status Following Non-HSCT Chemotherapy-treated Pediatric Leukemia Survivors.

Journal of pediatric hematology/oncology·2026
Same journal

Frequent Use of Hematologic Testing in Children Admitted for Nonaccidental Trauma.

Journal of pediatric hematology/oncology·2026
Same journal

Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock.

Journal of pediatric hematology/oncology·2026
Same journal

Local Control and Survival Outcomes in Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: The Mayo Clinic Experience.

Journal of pediatric hematology/oncology·2026
Same journal

Diagnostic Pitfalls in Pediatric Acute Promyelocytic Leukemia: All-trans Retinoic Acid-Associated Hypercalcemia Mimicking Fungal Meningitis and the Risks of Azole Coadministration.

Journal of pediatric hematology/oncology·2026
Same journal

Unmanipulated Haploidentical Stem Cell Transplantation Outcome in a Pediatric Patient With CD27 Deficiency and EBV-Induced Diffuse Large B-Cell Lymphoma With Primary CNS Involvement.

Journal of pediatric hematology/oncology·2026
See all related articles

A new classification system for childhood myelodysplastic syndromes (MDS) effectively categorizes pediatric patients. This system, unlike the FAB classification, shows prognostic potential and aids in tracking disease progression.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Clinical Classification Systems

Background:

  • Pediatric myelodysplastic syndromes (MDS) exhibit significant biological diversity.
  • The French-American-British (FAB) classification for adult MDS is often inadequate for pediatric cases.
  • Existing classification systems fail to adequately categorize many childhood MDS patients.

Purpose of the Study:

  • To develop and test a practical classification system for childhood MDS.
  • To address limitations of the FAB classification in pediatric patients.
  • To establish a uniform system for classifying pediatric MDS.

Main Methods:

  • Analysis of 40 pediatric MDS cases diagnosed between 1988 and 1998.
  • Classification based on three key features: category, cytology, and cytogenetics.

Related Experiment Videos

  • Exclusion of specific conditions like juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.

    • Main Results:

    • The developed classification system successfully categorized all 40 pediatric patients.
    • Approximately 50% of patients could not be classified using the FAB system.
    • The system allowed for longitudinal classification, demonstrating disease progression.

    Conclusions:

    • The new classification system (CCC) shows prognostic value in pediatric MDS.
    • Advanced disease class and cytogenetic abnormalities correlate with poorer outcomes.
    • International adoption is recommended for standardized clinical practice and reporting.